Projects per year
- 1 - 50 out of 63 results
Search results
-
Not started
-
GOG0274The OUTBACK Trial
Kamat, A. A., Alaniz, A., Butler, E. B., Farach, A. M., Morgan, P. B., Singh, M. & Suri, A.
Project: Clinical Trial
-
PALbociclib CoLlaborative Adjuvant Study: A Randomized Phase III Trial of Palbociclib With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive (HR+) / Human Epidermal Growth Factor Receptor 2
Niravath, P. A., Chang, J. C., Heyne, K. & Singh, M.
Project: Clinical Trial
-
A Randomized, Double-blind, Phase 3 Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer (ENGOT-0V44 The FIRST)
Suri, A., Alaniz, A., Singh, M. & Zaid, T.
Project: Clinical Trial
-
A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients With DCIS Following Breast Conserving Therapy
Templeton, S., Arentz, C., Chang, J. C., Darcourt, J., Dubrovsky, E., Haque, W. M., Heyne, K., Morgan, P. B., Niravath, P. A. & Singh, M.
Project: Clinical Trial
-
Phase III Randomized Study of Concurrent Chemotherapy and Pelvic Radiation Therapy With or Without Adjuvant Chemotherapy in High-Risk Patients With Early-Stage Cervical Carcinoma Following Radical Hysterectomy (RTOG 0724/GOG-0724 )
Kamat, A. A., Butler, E. B., Farach, A. M., Morgan, P. B., Singh, M. & Suri, A.
Project: Clinical Trial
-
An open-label, randomised, multicentre, phase III study of irinotecan liposome injection, oxaliplatin, 5-fluorouracil/leucovorin versus nab-paclitaxel plus gemcitabine in subjects who have not previously received chemotherapy for metastatic adenocarcinoma of the pancreas
Abdelrahim, M., Heyne, K. & Singh, M.
Project: Clinical Trial
-
-
-
-
GOG-3044 LAE002INT2001
Kamat, A. A., Alaniz, A., Ramirez, P. T., Singh, M., Suri, A. & Zaid, T.
Project: Clinical Trial
-
GOG 213
Kamat, A. A., Alaniz, A., Beinart, G., Coffey, D., Singh, M., Suri, A. & Zaid, T.
Project: Clinical Trial
-
A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed by Adjuvant Continuation of Atezolizumab or Placebo
Niravath, P. A., Abdelrahim, M., Arentz, C., Chang, J. C., Heyne, K. & Singh, M.
Project: Clinical Trial
-
A Randomized, Double-blind, Phase III Study, Comparing NIS793 in Combination With Gemcitabine and Nab-paclitaxel Versus (vs.) Placebo Combined With Gemcitabine and Nab-paclitaxel for First Line Treatment of Metastatic Pancreatic Ductal Adenocarcinoma
Abdelrahim, M., Heyne, K. & Singh, M.
Project: Clinical Trial
-
Phase Ib Trial of L-NMMA in Combination With Pembrolizumab in Patients With Melanoma, Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Classical Hodgkin Lymphoma, Urothelial Carcinoma, or Microsatellite Instability-High/Mismatch Repair
Zhang, J., Heyne, K. & Singh, M.
Project: Clinical Trial
-
-
-
A Randomized Phase III Trial of Radiation Therapy and Cisplatin Alone or in Combination With Intravenous Triapine in Women With Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer (NRG-GY006)
Zaid, T., Alaniz, A., Butler, E. B., Farach, A. M., Haque, W. M., Kamat, A. A., Morgan, P. B., Shadle, K. M., Shkedy, C., Singh, M. & Suri, A.
Project: Clinical Trial
-
Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Gemcitabine and Nab-paclitaxel for Front-line Treatment of Locally-advanced Pancreatic Adenocarcinoma
Abdelrahim, M., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Templeton, S.
Project: Clinical Trial
-
Acupuncture Trial
Niravath, P. A., Chang, J. C., Heyne, K., Mai, H. P., Singh, M. & Sun, K.
Project: Clinical Trial
-
Katherine, B50, for Treatment of Adjuvant HER2 Positive Breast Cancer
Chang, J. C., Niravath, P. A. & Singh, M.
Project: Clinical Trial
-
Circulating tumor DNA 5-hydroxymethylcytosine as a novel biomarker for cancers.
Li, Z., Bernicker, E. H., Chang, J. C., Darcourt, J., Pingali, S. R., Sahay, S., Shah, S., Singh, M., Zhang, J., Zhou, S. & Zu, Y.
Project: Clinical Trial
-
Active
Neoadjuvant Combination Therapy of Lenvima® plus Transcatheter Arterial Chemoembolization (TACE) for Transplant-Eligible Patients with Large Hepatocellular Carcinoma
Abdelrahim, M., Connor, A. A., Ghobrial, R. M., Graviss, E. A., Heyne, K., Kodali, S., Moore, L. W., Singh, M. & Victor, III, D. W.
5/12/23 → …
Project: Clinical Trial
-
An Open-label, Multicenter Trial of the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of M1774 in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301)
Singh, M., Abdelrahim, M., Heyne, K., Niravath, P. A. & Zhang, J.
7/25/22 → …
Project: Clinical Trial
-
A Study to Assess the Antitumor Activity and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma
Abdelrahim, M., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
5/2/22 → …
Project: Clinical Trial
-
Phase I Trial of Atezolizumab and Interleukin-12 Gene Therapy in Metastatic Non-Small Cell Lung Cancer With Progression on First-Line Immunotherapy With or Without Chemotherapy
Zhang, J., Chan, E. Y., Gibbs, J. M., Heyne, K., Kim, M. P., Singh, M. & Sultenfuss, M. A.
9/16/21 → …
Project: Clinical Trial
-
-
Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell Carcinoma-CoImmune CMN-001-1
Satkunasivam, R., Singh, M. & Zhang, J.
8/26/21 → …
Project: Clinical Trial
-
An Open-Label Randomized Active-Controlled Phase II Clinical Study to Assess the Efficacy and Safety of Afuresertib Plus Paclitaxel Versus Paclitaxel in Patients with Platinum-ResistantOvarian Cancer
Kamat, A. A., Alaniz, A., Darcourt, J., Singh, M., Suri, A. & Zaid, T.
3/15/21 → 3/14/46
Project: Non Profit
-
Sample and Data Collection for Houston Methodist Cancer Center Research
Chang, J. C., Bernicker, E. H., Darcourt, J., Heyne, K., Niravath, P. A. & Singh, M.
4/9/20 → …
Project: Clinical Trial
-
CTSU - IRB SUBMISSIONA Phase III Trial To Evaluate The Efficacy Of The Addition Of Inotuzumab Ozogamicin (A Conjugated Anti-Cd22 Monoclonal Antibody) To Frontline Therapy In Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL.
Abdelrahim, M., Bernicker, E. H., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
3/6/20 → 3/5/45
Project: Non Profit
-
Durvalumab vs Placebo Following Stereotactic Body Radiation Therapy in Early Stage Non-small Cell Lung Cancer Patients
Zhang, J., Haque, W. M., Heyne, K., Shadle, K. M. & Singh, M.
9/25/19 → …
Project: Clinical Trial
-
A phase III, multicenter, randomized, study of atezolizumab/placebo administered in combination with paclitaxel, carboplatin, and bevacizumab to patients with newly-diagnosed stage III or stage IV ovarian, fallopian tube, or primary peritoneal cancer
Kamat, A. A., Alaniz, A., Bernicker, E. H., Darcourt, J., Heyne, K., Singh, M., Suri, A. & Zaid, T.
3/13/18 → 3/12/43
Project: Non Profit